Open AccessSulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy
Author(s) -
Dali Christine í,
Barton Norman W.,
Farah Mohamed H.,
Moldovan Mihai,
Månsson JanEric,
Nair Nitin,
Dunø Morten,
Risom Lotte,
Cao Hongmei,
Pan Luying,
SellosMoura Marcia,
Corse Andrea M.,
Krarup Christian
Publication year - 2015
Publication title -
annals of clinical and translational neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.824
H-Index - 42
ISSN - 2328-9503
DOI - 10.1002/acn3.193
Subject(s) - metachromatic leukodystrophy , sural nerve , medicine , somatosensory evoked potential , central nervous system , peripheral neuropathy , myelin , motor nerve , pathology , endocrinology , neuroscience , anesthesia , anatomy , psychology , diabetes mellitus
Objective Metachromatic leukodystrophy ( MLD ) is an autosomal recessive lysosomal storage disorder due to deficient activity of arylsulfatase A ( ASA ) that causes accumulation of sulfatide and lysosulfatide. The disorder is associated with demyelination and axonal loss in the central and peripheral nervous systems. The late infantile form has an early‐onset, rapidly progressive course with severe sensorimotor dysfunction. The relationship between the degree of nerve damage and (lyso)sulfatide accumulation is, however, not established. Methods In 13 children aged 2–5 years with severe motor impairment, markedly elevated cerebrospinal fluid (CSF) and sural nerve sulfatide and lysosulfatide levels, genotype, ASA mRNA levels, residual ASA , and protein cross‐reactive immunological material ( CRIM ) confirmed the diagnosis. We studied the relationship between (lyso)sulfatide levels and (1) the clinical deficit in gross motor function ( GMFM ‐88), (2) median and peroneal nerve motor and median and sural nerve sensory conduction studies ( NCS ), (3) median and tibial nerve somatosensory evoked potentials ( SSEP s), (4) sural nerve histopathology, and (5) brain MR spectroscopy. Results Eleven patients had a sensory‐motor demyelinating neuropathy on electrophysiological testing, whereas two patients had normal studies. Sural nerve and CSF (lyso)sulfatide levels strongly correlated with abnormalities in electrophysiological parameters and large myelinated fiber loss in the sural nerve, but there were no associations between (lyso)sulfatide levels and measures of central nervous system ( CNS ) involvement ( GMFM ‐88 score, SSEP , and MR spectroscopy). Interpretation Nerve and CSF sulfatide and lysosulfatide accumulation provides a marker of disease severity in the PNS only; it does not reflect the extent of CNS involvement by the disease process. The magnitude of the biochemical disturbance produces a continuously graded spectrum of impairments in neurophysiological function and sural nerve histopathology.